Multiparametric magnetic resonance imaging in prostate cancer diagnostics
DOI:
https://doi.org/10.26641/2307-5279.21.1.2017.150086Keywords:
multiparametric magnetic resonance imaging, transrectal ultrasound investigation, prostate cancerAbstract
The article is dedicated to problem of significant prostate cancer diagnostics. Disadvantages of transrectal ultrasound guided prostate biopsy which lead to insufficient method’s sensitivity are analised. A lot of attention is given to opportunity of use of multiparametric mri before biopsy for determination and marking of suspicious tissue regions. Received data allow to make a conclusion about increase of prostate biopsy sensitivity with the help of prior mri and about increase of significant prostate cancer detection rate. It is shown that the use of mri decreases the amount of biopsy samples and reduces complication rate. The authors conclude that multiparametric mri is a perspective method for prostate cancer detection which needs to be improved on the base of further investigations.References
World Health Organization. Health Statistics and Information Systems: WHO Mortality Database: [Электронный ресурс]. URL: who.int/healthinfo/mortality_data/en/.
Рак в Україні 2014–2015. Бюлетень національного канцер-реєстру України № 17. Колесник О.О., Федоренко З.П., Гулак Л.О., Михайлович Ю.Й. – К., 2016.
Ferlay I., Shin H. GLOBOCAN 2012: Cancer incidence and mortality worldwide // IARC cancer base. – 2012. – N 10.
Welch H., Fisher S. Detection of prostate cancer via biopsy in the medicare-SEER population during PSA era // J. Natl. Cancer Inst. – 2007. – V. 99. – P. 1395–1400.
Hodge K., McNeal J. Ultrasound guided tansrectal core biopsies of the palpably abnormal prostate // J. Urol. – 1989. – V. 142. – P. 66–70.
Hodge K., McNeal J., Stamey T. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate // J. Urol. – 1989. – V. 142. – P. 71–74.
Schoots I., Roobol M. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis // Eur. Urol. – 2015. – V. 68(3). – P. 438–450.
Marks L., Young S. MRI-ultrasound fusion for guidence of targeted prostate biopsy // Curr. Opin. Urol. – 2013. – V. 23, N 1. – P. 43–50.
Cooperberg M., Broering J. Contemporary trends in low risk prostate cancer: risk assessment and treatment // J. Urol. – 2007. – V. 178. – P. 140–149.
Taira A., Merrick G. Perfomance of transperineal template-guided mapping biopsy in detecting prostate cancer inthe initial and repeat biopsy setting // Prostate cancer prostatic dis. – 2010. – V. 13. – P. 71–77.
Djavan B., Ravery A. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? // The journal of urology. – 2001. – V. 166, N 5. – P. 1679–1683.
Song J., Kim C. Prostate-specific antigen, digital rectal examination and transrectal ultrasonography: a meta-analysis for this diagnostic triad of prostate cancer in symptomatic korean men // Yonsei medical journal. – 2005. – V. 46. – P. 414–424.
Marks L., Young S. MRI-ultrasound fusion for guidance of targeted prostate biopsy // Curr. Opin. Urol. – 2013.
Welch H., Fisher E. Detection of prostate cancer via biopsy in the Medicare-Seer population during the PSA era // J. Natl. Cancer Inst. – 2007. – V. 99. – P. 1395–1400.
Raventos C., Orsola A. Preoperative production of insignificant prostate cancer: the role of prostate volume and the number of positive cores // Urol. Int. – 2010. – V. 84. – P. 153–158.
Taira A., Merrick G. Perfomance of transperineal mapping biopsy in detecting prostate cancer in the initial and repeat setting // Prostate Cancer Prostatic Dis. – 2010. – V. 13. – P. 71–77.
Peltier A., Aoun F. MRI-Targeted Biopsies versus Systematic Transrectal Ultrasound Guided Biopsies for the Diagnoses of Localized Prostate Cancer in Biopsy Naпve Men.
Hricak H., Williams R. Anatomy and pathology of the male pelvis by magnetic resonance imaging // AJR am J. Roentgenol. – 1983. – V. 141. – P. 1101–1110.
Hoeks C., Shouten M. Three-tesla magnetic resonance-guided prostate biopsy in men with increased PSA and repeated random systematic transrectal ultrasound biopsies: detection of clinically significant prostate cancers // European Urology. – 2012.
Moore C., Robertson N. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review // European urology. – 2012.
Sonn G., Margolis D. Target detection: magnetic resonance imaging-ultrasound fusion-guided prostate biopsy // Urologic oncology. – 2014. – V. 32. – P. 903–911.
Barentz J., Richenberg J. ESUR prostate MRI guidelines // Eur. Radiol. – 2012. – V. 22. – P. 746–757.
Hoeks C., Barentz J. Prostate cancer: multiparametric MR imaging for detection, localization and staging // Radiology. – 2011. – V. 261. – P. 46–66.
Stamey T., Freiha F. Localized prostate cancer. Relationship of tumour volume to clinical significance for treatment // Cancer. – 1993. – V. 71. – P. 933–938.
Ploussard G., Epstein J. The contemporary concept of significant versus insignificant prostate cancer // European Urology. – 2011. – V. 60. – P. 291–303.
Chan T., Stutzman K.. Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors? // J. Urol. – 2001. – V. 166. – P. 2181–2184.
Downloads
Published
Issue
Section
License
Стаття повинна мати візу керівника та офіційне направлення від установи, з якої виходить стаття (з круглою печаткою), і вказівкою, чи є стаття дисертаційною, а також у довільній формі на окремому аркуші - відомості про авторів (прізвище, ім’я, по батькові, посада, вчений ступінь, місце роботи, адреса, контактні телефони, E-mail).
Стаття повина бути підписана всіма авторами, які укладають з редакцією договір пропередачу авторських прав (заповнюється на кожного автора окремо з оригінальним підписом). За таких умов редакція має право на її публікацію та розміщення на сайті видавництва.
